Detection of In Vivo Activated Platelets in Experimental Cerebral Thrombosis: Studies Using a New Monoclonal Antibody 2T60, Specific for Activated Human and Rabbit Platelets

References

• Akkerman J W N, Nieuwenhuis H K, Sixma J J. Thrombosis and Atherosclerosis. II. Laboratory Diagnosis. Boehringer Ingelheim. 1986
   Google Scholar
• Sixma J J. The prethrombotic state. Br J Haematol 1980; 46: 515–522
   PubMedGoogle Scholar
• Zahavi J. Acquired storage pool disease of platelets. Thromb Haemost 1976; 35: 501–506
   PubMedGoogle Scholar
• Calvalho A C A, Rao A K. Acquired qualitative platelet defects. Hemostasis and thrombosis, R W Colman, J Hirsh, V J Marder, E W Salzman. Lippincott, Philadelphia 1987; 750–771
   Google Scholar
• Schattil S J, Hoxie J A, Cunningham M, Brass L F. Changes in the platelet membrane glycoprotein IIb/IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107–11114
   PubMedGoogle Scholar
• Hsu-Lin S C, Berman C L, Furie B C, August D, Furie B. A platelet membrane protein expressed during platelet activation and secretion. J Biol Chem 1984; 259: 9121–9126
   PubMed Web of Science ®Google Scholar
• McEver R P, Martin M N. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984; 259: 9799–9804
   PubMed Web of Science ®Google Scholar
• Tanoue K, Jung S M, Yamamoto N, Yamazaki H. Neutralization of the local negative charge carried by glycoprotein lb in ristocetin-induced platelet agglutination. Thromb Haemost 1984; 51: 79–83
   PubMed Web of Science ®Google Scholar
• Koehler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–497
   PubMed Web of Science ®Google Scholar
• Bolton A E, Hunter W M. Radioimmunoassay and related methods. Handbook of experimental Immology. vol. 1 (ed. 4), D M Weir, OxfordEngland 1986; 26.1–26.56
   Google Scholar
• Laudano A P, Doolittle R F. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry 1980; 19: 1013–1019
   PubMedGoogle Scholar
• Yamamoto N, Kitagawa H, Yamamoto K, Tanoue K, Yamazaki H. Calcium ions and the conformation of glycoprotein IIIa that is essential for fibrinogen binding to platelets: Analysis by a new monoclonal anti-GPIIIa antibody, TM83. Blood 1989; 73: 1552–1560
   PubMedGoogle Scholar
• Laemmli U K. Cleavage of structure proteins during the assembly of the head bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Fraker P J, Speck J C, Jr. Protein and cell membrane iodinations with a sparingly soluble chlomoamide, 1,3,4,6-tetrachloro-3a,6a,-diphenylglycoluril. Biochem Biophysic Res Commun 1978; 80: 849–857
   PubMed Web of Science ®Google Scholar
• Hagen I, Nurden A, Bjerrum O J, Solum N O, Caen J P. Immunochemical evidence for protein abnormalities in platelets from patients Glanzmann's thrombasthenia and the Bernard-Soulier syndrome. J Clin Invest 1980; 65: 722–731
   PubMedGoogle Scholar
• Tanoue K, Hasegawa S, Yamaguchi A, Yamamoto N, Yamazaki H. A new variant of thrombasthenia with abnormally glycosylated GPIIb/IIIa. Thromb Res 1987; 47: 323–333
   PubMedGoogle Scholar
• Phillips D R. Effect of trypsin on the exposed polypeptides and glycoproteins of human platelet membranes. Biochemistry 1972; 11: 4582–4588
   PubMed Web of Science ®Google Scholar
• Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987; 262: 10035–10038
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Suzuki H, Tanoue K, Fukushima Y, Yamazaki H. Cerebrovascular injuries induced by activation of platelets in vivo. Stroke 1985; 16: 245–250
   PubMedGoogle Scholar
• Johnston G I, Cook R G, McEver R P. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989; 56: 1033–1044
   PubMed Web of Science ®Google Scholar
• Coller B S. Activation-specific platelet antigens. Platelet immunobiology, T J Kunicki, J N George. Lippincott, Philadelphia 1989; 166–189
   Google Scholar
• Dechavanne M, Ffrench M, Pages J, et al. Significant reduction in the binding of a monoclonal antibody (LYP 18) directed against the IIb/IIIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation. Thromb Haemost 1987; 57: 106–109
   PubMed Web of Science ®Google Scholar
• Gogstad G O, Krutnes M B, Hetland O, Solum N O. Comparison of proteins and lipid composition of the human platelet alpha-granule membranes and glycerol lysis membranes. Biochim Biophys Acta 1983; 732: 519–530
   PubMedGoogle Scholar
• Stenberg P E, McEver R P, Shuman M A, Jacques Y V, Bainton D F. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880–886
   PubMed Web of Science ®Google Scholar
• Johnston G I, Kurosky A, McEver R P. Structural and biosynthetic studies of the granular membrane protein. GMP-140, from human platelets and endothelial cells. J Biol Chem 1989; 264: 1816–1823
   PubMedGoogle Scholar
• McEver R P, Beckstead J H, Moore K, Marshall-Carlson L, Bainton D F. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endotherial cells and localized in Weibel-Palade bodies. J Clin Invest 1989; 84: 92–99
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Suzuki H, Tanoue K, Fukushima Y, Yamazaki H. Autoradiographic observation of platelets in cerebrovascular injuries by arachidonic acid and its prevention by Ticlopidine. Thromb Haemost 1988; 60: 319–323
   PubMed Web of Science ®Google Scholar